These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1742957)

  • 21. [The effects of treatment with atenolol and benazapril on 24-hour pressure variability].
    Prattichizzo FA; Galetta F
    Minerva Cardioangiol; 1993 Dec; 41(12):587-90. PubMed ID: 8139779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of combination of valsartan with benazepril on blood pressure and left ventricular hypertrophy in SHR.
    Ke YS; Cao H; Yang T
    Acta Pharmacol Sin; 2000 Nov; 21(11):1043-7. PubMed ID: 11501062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antihypertensive action of the novel angiotensin converting enzyme inhibitor benazepril hydrochloride in hypertensive rat models.
    Tanaka M; Yamamoto S; Nakao K; Inukai T; Ogawa N; Katsumura H; Ohara N; Shukunobe K; Ono H
    Arzneimittelforschung; 1991 Jun; 41(6):608-12. PubMed ID: 1930348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of clinical and ambulatory measurements of blood pressure with benazepril alone or combined with hydrochlorothiazide in hypertension].
    Le Feuvre C; Francillon A; Renucci JF; Cocco-Guyomarch L; Muller M; Peuplier P; Poggi L
    Therapie; 1996; 51(1):27-34. PubMed ID: 8762217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of simvastatin on cardiac fibrosis in patients with essential hypertension].
    Zhang GG; Zhang SD
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 30(3):280-2. PubMed ID: 16045013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benazepril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and congestive heart failure.
    Balfour JA; Goa KL
    Drugs; 1991 Sep; 42(3):511-39. PubMed ID: 1720384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Angiotensin-converting enzyme inhibitors in the treatment of hypertension in Air Force personnel].
    Godilo-Godlevskiĭ VA; Nagovitsyn AV; Toporishcheva OS; Vovkodav VS
    Voen Med Zh; 2009 May; 330(5):55-7. PubMed ID: 19663210
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of benazepril on insulin resistance and glucose tolerance in uremia.
    Wu Z; Bao X
    Clin Nephrol; 1998 Aug; 50(2):108-12. PubMed ID: 9725782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antihypertensive therapy using a combination of angiotensin 1 receptor inhibitors with angiotensin-converting enzyme inhibitors].
    Meyer GJ
    Dtsch Med Wochenschr; 1998 May; 123(21):681. PubMed ID: 9638097
    [No Abstract]   [Full Text] [Related]  

  • 31. An open clinical trial of benazepril--a new ACE inhibitor in mild-moderate hypertension.
    Karnik ND; Oza YK; Sane SP; Kaushik R; Bhatt AD; Chawla KP; Vaidya AB; Yajnik VH; Khokhani RC
    J Assoc Physicians India; 1998 Mar; 46(3):283-5. PubMed ID: 11273348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of benazepril plus hydrochlorothiazide versus benazepril alone in hypertensive patients unresponsive to benazepril monotherapy.
    Holwerda K; Hoogma RP; Oldenbroek C; Huige RC; Wester A; Rijnierse JM
    Clin Ther; 1994; 16(6):942-51. PubMed ID: 7697691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of combination therapy with atenolol and the angiotensin-converting enzyme inhibitor benazepril.
    Bursztyn M; Gavras I; Gourley L; DeSilva J; Whalen J; Gavras H
    Clin Ther; 1994; 16(3):429-36. PubMed ID: 7923309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term effects of benazepril on ambulatory blood pressure, left ventricular mass, diastolic filling and aortic flow in essential hypertension.
    Porcellati C; Verdecchia P; Schillaci G; Boldrini F; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1991 May; 29(5):187-97. PubMed ID: 1830037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension.
    Bakris GL; Toto RD; McCullough PA
    J Hum Hypertens; 2005 Feb; 19(2):139-44. PubMed ID: 15457206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis on the trend of long-term change of blood pressure in hypertensive patients treated with benazepril].
    Lu J; Li LM; He PP; Cao WH; Zhan SY; Hu YH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):537-40. PubMed ID: 15231142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin-converting-enzyme inhibitors and diuretics for hypertension.
    Krut LH
    N Engl J Med; 2003 Jul; 349(1):90-3; author reply 90-3. PubMed ID: 12846227
    [No Abstract]   [Full Text] [Related]  

  • 38. Dose-response studies with benazepril in mild to moderate hypertension.
    Gomez HJ
    Clin Cardiol; 1991 Aug; 14(8 Suppl 4):IV22-7; discussion IV51-5. PubMed ID: 1893638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin-converting-enzyme inhibitors and diuretics for hypertension.
    Pickering TG
    N Engl J Med; 2003 Jul; 349(1):90-3; author reply 90-3. PubMed ID: 12840099
    [No Abstract]   [Full Text] [Related]  

  • 40. Angiotensin-converting-enzyme inhibitors and diuretics for hypertension.
    Reese AM; Talbert RL; Bussey HI
    N Engl J Med; 2003 Jul; 349(1):90-3; author reply 90-3. PubMed ID: 12846228
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.